NCT03353337 is a NA clinical trial of aerobic exercise in Bipolar Disorder, sponsored by Guangzhou Psychiatric Hospital.

Who is sponsoring NCT03353337?

NCT03353337 is sponsored by Guangzhou Psychiatric Hospital.

What drugs are being tested in NCT03353337?

Interventions in NCT03353337: aerobic exercise, Placebo controlled group.

What condition does NCT03353337 study?

NCT03353337 studies Bipolar Disorder, Cognitive Symptom.

Is NCT03353337 still recruiting?

NCT03353337 is currently status unknown. Last updated 27 November 2017.

Last reviewed 2017-11-27 · How we verify

NCT03353337

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study of Aerobic Exercise for Patients With Bipolar Disorder

Status unknown NA Last updated 27 November 2017

What this trial tests

NA trial testing aerobic exercise in Bipolar Disorder in 210 participants. Status unknown.

Timeline

1 December 2017

Primary endpoint
31 July 2019

31 December 2019

Quick facts

Lead sponsor	Guangzhou Psychiatric Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	210
Start date	1 December 2017
Primary completion	31 July 2019
Estimated completion	31 December 2019
Sites	1 location across China

Drugs / interventions tested

aerobic exercise — full drug profile →
Placebo controlled group

Conditions studied

Bipolar Disorder — all drugs for Bipolar Disorder →
Cognitive Symptom — all drugs for Cognitive Symptom →

Sponsor

Guangzhou Psychiatric Hospital

Who can join

Adults 18 to 60, any sex, with Bipolar Disorder or Cognitive Symptom. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will investigate the effects of aerobic exercise on mental states, cognition, BDNF, and long-term outcomes in patients with bipolar disorder.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of aerobic exercise

Trials testing the same drug.

NCT07326228 — Effect of Exercises on Ventilatory Function in Adult With TOF · NA · not yet recruiting
NCT07139275 — Insulin Sensitivity and Testosterone Response to Aerobic Exercise Versus Added Sugar Elimination in Polycystic Ovary Syn · NA · not yet recruiting
NCT07073716 — TAC, SOD and MDA Responses to Aerobic Exercise Versus Phoenix Seed in Obese Sedentary Females · NA · not yet recruiting
NCT07003711 — Effects of Progressive Muscle Relaxation Training Applied in Addition to Aerobic Exercise Training in Individuals With M · NA · completed
NCT06838299 — Two Different Renal Rehabilitation Protocols in Hemodialysis Patients · NA · completed

Other recruiting trials for Bipolar Disorder

Currently open trials in the same condition.

NCT06758414 — CBT-CP for Veterans With SMI · NA · recruiting
NCT06911931 — Visual Perception in Schizophrenia · NA · recruiting
NCT07316803 — Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · NA · recruiting
NCT07479758 — Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Out · recruiting
NCT07140913 — A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Featur · Phase 3 · recruiting

Other Guangzhou Psychiatric Hospital trials

Trials by the same sponsor.

NCT06658795 — Treating Loneliness In The Older Adult With Depression With tDCS · NA · recruiting
NCT04816617 — The Effect of Exercise on Cognition and Preventing Depression in Young People · NA · completed
NCT04803071 — Omega-3 Unsaturated Fatty Acid Improves Cognitive Function in Patients With Depression · NA · unknown
NCT04447430 — Light Therapy to Improve Symptoms in Pregnant Women With Major Depressive Disorder · NA · unknown
NCT04124276 — Evaluation of Efficacy of Lycium Barbarum Polysaccharide in Patients With Major Depressive Disorder · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03353337 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Guangzhou Psychiatric Hospital
Last refreshed: 27 November 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03353337.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing